Preparation and application of light-triggered erythrocyte membrane wrapped NO nano bionic donor material
A red blood cell membrane and nano-bionic technology, applied in the field of biomedical engineering materials, can solve the problems of NO nano-donor materials in the field of tumor treatment, difficult application of NO nano-donor materials, poor stability of NO donor materials, etc., to achieve inhibition Effects of tumor growth and distant metastasis, excellent cell specificity, and prolonged blood circulation time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Synthesis of polydopamine nanoparticles encapsulated by thiolated mesoporous silica (PDA@mSiO 2 )
[0058] a. Add tris(hydroxymethyl)aminomethane to a certain volume of deionized water at a room temperature of 15°C to form a certain concentration of Tris-HCl buffer solution, and then add a certain volume of isopropanol (IPA) to adjust the pH value of the mixed solution to 8.0, add dopamine hydrochloride under vigorous stirring. After continuous stirring for 2 days, the polydopamine nanoparticles were collected by centrifugation at 40,000 g for 10 min, and washed twice with deionized water and ethanol respectively to obtain polydopamine (PDA) nanoparticles. The molar ratio of Tris-HCl to dopamine hydrochloride is 1:0.1; the purity of the isopropanol is ACS, ≥99.5%; the volume ratio of the Tris-HCl buffer to isopropanol is 1:0.2; the Add 10 mg of tris(hydroxymethyl)aminomethane per 10 mL of deionized water.
[0059] b. Disperse the polydopamine nanoparticles obtained i...
Embodiment 2
[0061] Synthesis of polydopamine nanoparticles encapsulated by thiolated mesoporous silica (PDA@mSiO 2 )
[0062]c. Add tris(hydroxymethyl)aminomethane to a certain volume of deionized water at a room temperature of 25°C to form a certain concentration of Tris-HCl buffer solution, and then add a certain volume of isopropanol (IPA) to adjust the pH value of the mixed solution to 9.0, add dopamine hydrochloride under vigorous stirring. After continuous stirring for 4 days, the polydopamine nanoparticles were collected by centrifugation at 60000 g for 20 min, and washed three times with deionized water and ethanol respectively to obtain polydopamine (PDA) nanoparticles. The molar ratio of Tris-HCl to dopamine hydrochloride is 1:0.5; the purity of the isopropanol is ACS, ≥99.5%; the volume ratio of the Tris-HCl buffer to isopropanol is 1:0.5; the Add 15 mg of tris(hydroxymethyl)aminomethane per 10 mL of deionized water.
[0063] d. Disperse the polydopamine nanoparticles obtain...
Embodiment 3
[0065] Preparation of double-loaded polydopamine@mesoporous silica nanoparticles (PDA@mSiO 2 / SNO / DOX)
[0066] e. At room temperature, disperse the thiolated polydopamine@mesoporous silica nanoparticles and tert-butyl nitrite obtained in Example 1 in a mixed solution of 10 mL of methanol and toluene, and keep stirring for 24 hours under the protection of nitrogen in the dark. Then centrifuged at 9000rpm for 10min, washed twice with absolute ethanol, and dried at room temperature to finally obtain NO-loaded polydopamine@mesoporous silica nanoparticles (PDA@mSiO 2 / SNO); the mass ratio of the thiolated polydopamine@mesoporous silica nanoparticles to t-butyl nitrite is 1:1; the volume ratio of the two components in the mixed solution of methanol and toluene is 1:4 .
[0067] f. PDA@mSiO obtained by taking a certain mass of step e at room temperature 2 / SNO dispersed in absolute ethanol, then add a certain quality of doxorubicin hydrochloride (DOX), keep stirring in the dark f...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com